Author

Andie Edwards

Observed name: Andie R Edwards

Institution: Medical University of South Carolina

Observed institutions: Medical University of South Carolina, MUSC Hollings Cancer Center

OpenAlex ID: A5070748396

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

2018 · John M Wrangle, Vamsidhar Velcheti, et al. · The Lancet Oncology · 412

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

2018 · Melanie B. Thomas, Elizabeth Garrett-Mayer, et al. · Oncology · 47

The National Conference on Health Disparities Student Research Forum

2021 · Marvella E. Ford, Angela M. Malek, et al. · Journal of Cancer Education · 1

Abstract PO-057: The National Conference on Health Disparities Student Research Forum

2022 · Marvella E. Ford, Angela M. Malek, et al. · Cancer Epidemiology Biomarkers & Prevention

Works count: 4

Citation count: 460

H-index: 2

I10-index: 2